These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 17177831

  • 1. The strength of the chemotactic response to a CCR5 binding chemokine is determined by the level of cell surface CCR5 density.
    Desmetz C, Lin YL, Mettling C, Portalès P, Rabesandratana H, Clot J, Corbeau P.
    Immunology; 2006 Dec; 119(4):551-61. PubMed ID: 17177831
    [Abstract] [Full Text] [Related]

  • 2. Cell surface CCR5 density determines the intensity of T cell migration towards rheumatoid arthritis synoviocytes.
    Desmetz C, Lin YL, Mettling C, Portalès P, Noël D, Clot J, Jorgensen C, Corbeau P.
    Clin Immunol; 2007 May; 123(2):148-54. PubMed ID: 17363330
    [Abstract] [Full Text] [Related]

  • 3. Identification of a chemokine network that recruits FoxP3(+) regulatory T cells into chronically inflamed intestine.
    Kang SG, Piniecki RJ, Hogenesch H, Lim HW, Wiebke E, Braun SE, Matsumoto S, Kim CH.
    Gastroenterology; 2007 Mar; 132(3):966-81. PubMed ID: 17324406
    [Abstract] [Full Text] [Related]

  • 4. Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes.
    Jalonen TO, Pulkkinen K, Ukkonen M, Saarela M, Elovaara I.
    J Neurol; 2002 May; 249(5):576-83. PubMed ID: 12021948
    [Abstract] [Full Text] [Related]

  • 5. Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5.
    Nattermann J, Nischalke HD, Feldmann G, Ahlenstiel G, Sauerbruch T, Spengler U.
    J Viral Hepat; 2004 Nov; 11(6):519-26. PubMed ID: 15500552
    [Abstract] [Full Text] [Related]

  • 6. The chemokine CCL5 regulates the in vivo cell surface expression of its receptor, CCR5.
    Lin YL, Mettling C, Portalès P, Rouzier R, Clot J, Reynes J, Corbeau P.
    AIDS; 2008 Jan 30; 22(3):430-2. PubMed ID: 18195571
    [Abstract] [Full Text] [Related]

  • 7. The efficiency of R5 HIV-1 infection is determined by CD4 T-cell surface CCR5 density through G alpha i-protein signalling.
    Lin YL, Mettling C, Portalès P, Réant B, Robert-Hebmann V, Reynes J, Clot J, Corbeau P.
    AIDS; 2006 Jun 26; 20(10):1369-77. PubMed ID: 16791011
    [Abstract] [Full Text] [Related]

  • 8. Determinants of CCL5-driven mononuclear cell migration across the blood-brain barrier. Implications for therapeutically modulating neuroinflammation.
    Ubogu EE, Callahan MK, Tucky BH, Ransohoff RM.
    J Neuroimmunol; 2006 Oct 26; 179(1-2):132-44. PubMed ID: 16857269
    [Abstract] [Full Text] [Related]

  • 9. The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection.
    Larrubia JR, Calvino M, Benito S, Sanz-de-Villalobos E, Perna C, Pérez-Hornedo J, González-Mateos F, García-Garzón S, Bienvenido A, Parra T.
    J Hepatol; 2007 Nov 26; 47(5):632-41. PubMed ID: 17560677
    [Abstract] [Full Text] [Related]

  • 10. Involvement of CCR5 in the passage of Th1-type cells across the blood-retina barrier in experimental autoimmune uveitis.
    Crane IJ, Xu H, Wallace C, Manivannan A, Mack M, Liversidge J, Marquez G, Sharp PF, Forrester JV.
    J Leukoc Biol; 2006 Mar 26; 79(3):435-43. PubMed ID: 16365158
    [Abstract] [Full Text] [Related]

  • 11. The chemoattraction of lymphocytes by rheumatoid arthritis - synovial fluid is not dependent on the chemokine receptor CCR5.
    Santiago B, Galindo M, Rivero M, Brehmer MT, Mateo I, Pablos JL.
    Rheumatol Int; 2002 Jul 26; 22(3):107-11. PubMed ID: 12111085
    [Abstract] [Full Text] [Related]

  • 12. Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling.
    Rabin RL, Park MK, Liao F, Swofford R, Stephany D, Farber JM.
    J Immunol; 1999 Apr 01; 162(7):3840-50. PubMed ID: 10201901
    [Abstract] [Full Text] [Related]

  • 13. Tick saliva inhibits the chemotactic function of MIP-1alpha and selectively impairs chemotaxis of immature dendritic cells by down-regulating cell-surface CCR5.
    Oliveira CJ, Cavassani KA, Moré DD, Garlet GP, Aliberti JC, Silva JS, Ferreira BR.
    Int J Parasitol; 2008 May 01; 38(6):705-16. PubMed ID: 18023445
    [Abstract] [Full Text] [Related]

  • 14. Expression of CCL5 (RANTES) and CCR5 in prostate cancer.
    Vaday GG, Peehl DM, Kadam PA, Lawrence DM.
    Prostate; 2006 Feb 01; 66(2):124-34. PubMed ID: 16161154
    [Abstract] [Full Text] [Related]

  • 15. A novel CCR5-specific pharmacodynamic assay in whole blood using phosphoflow cytometry highlights different ligand-dependent responses but similar properties of antagonists in CD8+ and CD4+ T lymphocytes.
    Dahl ME, Berson A, Lora J, Fuentes M.
    J Pharmacol Exp Ther; 2008 Dec 01; 327(3):926-33. PubMed ID: 18753410
    [Abstract] [Full Text] [Related]

  • 16. Aberrant responsiveness to RANTES in synovial fluid T cells from patients with rheumatoid arthritis.
    Hisakawa N, Tanaka H, Hosono O, Nishijima R, Ohashi Y, Saito S, Nishiya K, Hashimoto K, Morimoto C.
    J Rheumatol; 2002 Jun 01; 29(6):1124-34. PubMed ID: 12064824
    [Abstract] [Full Text] [Related]

  • 17. Serial changes in the expression of CXCR3 and CCR5 on peripheral blood lymphocytes following human renal transplantation.
    Inston N, Drayson M, Ready A, Cockwell P.
    Exp Clin Transplant; 2007 Dec 01; 5(2):638-42. PubMed ID: 18194114
    [Abstract] [Full Text] [Related]

  • 18. Polyclonal proliferation and apoptosis of CCR5+ T lymphocytes during primary human immunodeficiency virus type 1 infection: regulation by interleukin (IL)-2, IL-15, and Bcl-2.
    Zaunders JJ, Moutouh-de Parseval L, Kitada S, Reed JC, Rought S, Genini D, Leoni L, Kelleher A, Cooper DA, Smith DE, Grey P, Estaquier J, Little S, Richman DD, Corbeil J.
    J Infect Dis; 2003 Jun 01; 187(11):1735-47. PubMed ID: 12751031
    [Abstract] [Full Text] [Related]

  • 19. Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis.
    Mack M, Brühl H, Gruber R, Jaeger C, Cihak J, Eiter V, Plachý J, Stangassinger M, Uhlig K, Schattenkirchner M, Schlöndorff D.
    Arthritis Rheum; 1999 May 01; 42(5):981-8. PubMed ID: 10323454
    [Abstract] [Full Text] [Related]

  • 20. Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression.
    Zhang Y, Yao F, Yao X, Yi C, Tan C, Wei L, Sun S.
    Oncol Rep; 2009 Apr 01; 21(4):1113-21. PubMed ID: 19288016
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.